Prestige Consumer Healthcare, Inc. (PBH)
51.78
-0.69
(-1.32%)
USD |
NYSE |
Aug 31, 16:00
51.80
+0.02
(+0.04%)
After-Hours: 20:00
Prestige Consumer Healthcare Cash from Operations (TTM) : 249.40M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 249.40M |
| March 31, 2026 | 257.63M |
| December 31, 2025 | 276.63M |
| September 30, 2025 | 263.44M |
| June 30, 2025 | 275.75M |
| March 31, 2025 | 251.52M |
| December 31, 2024 | 256.57M |
| September 30, 2024 | 262.96M |
| June 30, 2024 | 255.62M |
| March 31, 2024 | 248.93M |
| December 31, 2023 | 241.01M |
| September 30, 2023 | 224.48M |
| June 30, 2023 | 219.56M |
| March 31, 2023 | 229.72M |
| December 31, 2022 | 233.86M |
| September 30, 2022 | 245.21M |
| June 30, 2022 | 248.86M |
| March 31, 2022 | 259.92M |
| December 31, 2021 | 255.88M |
| September 30, 2021 | 238.81M |
| June 30, 2021 | 229.76M |
| March 31, 2021 | 235.61M |
| December 31, 2020 | 232.65M |
| September 30, 2020 | 241.42M |
| June 30, 2020 | 239.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 217.12M |
| December 31, 2019 | 211.84M |
| September 30, 2019 | 197.18M |
| June 30, 2019 | 186.21M |
| March 31, 2019 | 189.28M |
| December 31, 2018 | 192.88M |
| September 30, 2018 | 196.68M |
| June 30, 2018 | 211.84M |
| March 31, 2018 | 210.11M |
| December 31, 2017 | 163.10M |
| September 30, 2017 | 156.03M |
| June 30, 2017 | 151.15M |
| March 31, 2017 | 147.77M |
| December 31, 2016 | 178.25M |
| September 30, 2016 | 184.04M |
| June 30, 2016 | 181.57M |
| March 31, 2016 | 174.35M |
| December 31, 2015 | 188.56M |
| September 30, 2015 | 189.79M |
| June 30, 2015 | 170.10M |
| March 31, 2015 | 156.26M |
| December 31, 2014 | 134.86M |
| September 30, 2014 | 113.04M |
| June 30, 2014 | 118.74M |
| March 31, 2014 | 111.58M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Indivior Pharmaceuticals, Inc. | -48.64M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 27.61B |